Influenza Challenge Study to Determine the Optimal Infection Dose and Safety of a Recombinant H3N2 (A/Texas/71/2017 (H3N2, Clade 3C3a) Influenza Strain
Clinical trial NCT04978454 · COMPLETED
Trial details
- NCT number
- NCT04978454
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-19
- Primary completion
- 2022-09-22
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.